Management of febrile neutropenic patients on anti-cancer therapy include all except:
High-Yield Explanation
Transfusion of granulocytes in febrile neutropenic patients has no role because Exceedingly sho half-life Mechanical fragility Pulmonary compromise with leukostasis after their use Instead, colony-stimulating factors (CSFs) are used to augment bone marrow production of PMNs . ref - pubmed.com